FDA approves first drug for NASH — a severe form of fatty liver disease
A Yale Medicine expert discusses Rezdiffra, a new treatment for a serious subtype of fatty liver disease that is not caused by heavy alcohol use.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Alcoholism | Fatty Liver Disease (FLD) | Health | Liver | Liver Disease | Science | Universities & Medical Training | Urology & Nephrology | Yale